CRBP
Corbus Pharmaceuticals Holdings, Inc. · Healthcare
CEO Yuval Cohen sold $108K of Corbus Pharmaceuticals Holdings, Inc.
Sold$107,952
$7.78Price
13,871Shares
−7%Stake
What CRBP did after the filing
- The stock from Wed, Feb 18 close, $7.41
- +34.7%
- S&P 500, same days
- −4.5%
Measured over 30 trading days, to the Apr 1 close.
Traded Fri, Feb 13. Filed Wed, Feb 18, 11:30 AM ET, during the session. Returns use the Feb 18 close and the Apr 1 close. Not investment advice.